Publicacións (14) Publicacións de MARIA JOSEFA NATIVIDAD GUERRA SEIJAS

filter_list Neurology

2018

  1. Bidirectional Neural Interaction Between Central Dopaminergic and Gut Lesions in Parkinson’s Disease Models

    Molecular Neurobiology, Vol. 55, Núm. 9, pp. 7297-7316

2017

  1. Brain renin-angiotensin system and microglial polarization: Implications for aging and neurodegeneration

    Frontiers in Aging Neuroscience, Vol. 9, Núm. MAY

2015

  1. Rho Kinase and Dopaminergic Degeneration: A Promising Therapeutic Target for Parkinsons Disease

    Neuroscientist, Vol. 21, Núm. 6, pp. 616-629

2014

  1. Effect of chronic treatment with angiotensin type 1 receptor antagonists on striatal dopamine levels in normal rats and in a rat model of Parkinson's disease treated with l-DOPA

    Neuropharmacology, Vol. 76, Núm. PART A, pp. 156-168

  2. Inhibition of the microglial response is essential for the neuroprotective effects of Rho-kinase inhibitors on MPTP-induced dopaminergic cell death

    Neuropharmacology, Vol. 85, pp. 1-8

  3. Microglial TNF-α mediates enhancement of dopaminergic degeneration by brain angiotensin

    GLIA, Vol. 62, Núm. 1, pp. 145-157

2012

  1. Involvement of microglial RhoA/Rho-Kinase pathway activation in the dopaminergic neuron death. Role of angiotensin via angiotensin type 1 receptors

    Neurobiology of Disease, Vol. 47, Núm. 2, pp. 268-279

2008

  1. Brain angiotensin enhances dopaminergic cell death via microglial activation and NADPH-derived ROS

    Neurobiology of Disease, Vol. 31, Núm. 1, pp. 58-73

2005

  1. Angiotensin II and interleukin-1 interact to increase generation of dopaminergic neurons from neurospheres of mesencephalic precursors

    Developmental Brain Research, Vol. 158, Núm. 1-2, pp. 120-122

  2. Glial overexpression of heme oxygenase-1: A histochemical marker for early stages of striatal damage

    Journal of Chemical Neuroanatomy, Vol. 29, Núm. 2, pp. 113-126

1998

  1. Interaction between the serotonergic, dopaminergic, and glutamatergic systems in fenfluramine-induced Fos expression in striatal neurons

    Synapse, Vol. 28, Núm. 1, pp. 71-82

  2. The overall rod performance test in the MPTP-treated-mouse model of Parkinsonism

    Journal of Neuroscience Methods, Vol. 83, Núm. 2, pp. 165-175

1997

  1. Treadmill running induces striatal Fos expression via NMDA glutamate and dopamine receptors

    Experimental Brain Research, Vol. 115, Núm. 3, pp. 458-468

1996

  1. Time course of striatal changes induced by 6-hydroxydopamine lesion of the nigrostriatal pathway, as studied by combined evaluation of rotational behaviour and striatal Fos expression

    Experimental Brain Research, Vol. 108, Núm. 1, pp. 69-84